Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $270,682 - $326,811
-4,100 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$63.34 - $74.11 $259,694 - $303,851
4,100 New
4,100 $301,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Q Pula Trading Management LP Portfolio

Follow Q Pula Trading Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Q Pula Trading Management LP with notifications on news.